Scilex Pharmaceuticals received approval from the FDA for ZTlido (lidocaine topical system) 1.8% for the relief of pain associated with...
Moderna, Inc. has announced it has received emergency use authorization (EUA) from the FDA for its BA.4/BA.5 Omicron-targeting bivalent COVID-19 booster vaccine, mRNA-1273.222, in children 6 months through 5 years of age
Boehringer Ingelheim has announced new data analyses from the pivotal Phase III TONADO 1&2 studies, which explored the efficacy and...